The functions of GPR120 in the adipose tissue can be linked to pathological ramifications of obesity (41, 43, 99, 100); thus, GPR120 as a target for the development of novel compounds to treat metabolic syndrome becomes a very promising approach. Here, FFAR4 is linked to obesity due to melanocortin 4 receptor deficiency.